Tularik Inc. (TLRK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who started this subject	10/18/2002 9:24:56 AM
From: nigel bates	Read Replies (1) of 598

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct. 18, 2002--Tularik Inc. (Nasdaq:TLRK - News) today announced that it has priced an offering of 4,000,000 shares of its common stock. Net proceeds to the Company are expected to be approximately $25.7 million. Goldman, Sachs & Co. is acting as underwriter. All of the shares are being offered by Tularik under its currently effective shelf registration statement. A registration statement relating to these securities was filed with and has been declared effective by the U.S. Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The shares of common stock may only be offered by means of a prospectus, copies of which can be obtained from Goldman, Sachs & Co., 85 Broad Street, New York, New York 10004.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next